FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Chiaki Sano

Research Profile

Living Beings

Anatomy

Disorders

Mycobacterium avium-intracellulare Infection

Chemicals & Drugs

Procedures

Microbial Sensitivity Tests

Concepts & Ideas

Virulence

Co-author Network

Publications

TOP 3
Yutaka Tatano; Masako Emori; Hajime Saito; Chiaki Sano; Katsumasa Sato; Toshiaki Shimizu; Haruaki Tomioka
[Phagocytosis of Mycobacterium leprae down-regulates anti-microbial activity of murine macrophages against Mycobacterium intracellulare].
Yutaka Tatano; S Yano; K Yasumoto; T Matsumoto; K Nishimori; Chiaki Sano; Katsumasa Sato; Toshiaki Shimizu; H Takeyama; Haruaki Tomioka
Correlation between variable-number tandem-repeat-based genotypes and drug susceptibility in Mycobacterium avium isolates.
Haruaki Tomioka; Yutaka Tatano; Yuichi Kanehiro; WW Maw; Chiaki Sano; Toshiaki Shimizu
Characteristics of suppressor macrophages induced by mycobacterial and protozoal infections in relation to alternatively activated M2 macrophages.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Chiaki Sano (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Yutaka Tatano; Masako Emori; Hajime Saito; Chiaki Sano; Katsumasa Sato; Toshiaki Shimizu; Haruaki Tomioka
[Phagocytosis of Mycobacterium leprae down-regulates anti-microbial activity of murine macrophages against Mycobacterium intracellulare].
Nihon Hansenbyō Gakkai zasshi = Japanese journal of leprosy : official organ of the Japanese Leprosy Association 2012;81(3):175-83.
2012: Yutaka Tatano; S Yano; K Yasumoto; T Matsumoto; K Nishimori; Chiaki Sano; Katsumasa Sato; Toshiaki Shimizu; H Takeyama; Haruaki Tomioka
Correlation between variable-number tandem-repeat-based genotypes and drug susceptibility in Mycobacterium avium isolates.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2012;31(4):445-54.
2012: Haruaki Tomioka; Yutaka Tatano; Yuichi Kanehiro; WW Maw; Chiaki Sano; Toshiaki Shimizu
Characteristics of suppressor macrophages induced by mycobacterial and protozoal infections in relation to alternatively activated M2 macrophages.
Clinical & developmental immunology 2012;2012():635451.
2011: Haruaki Tomioka; Yutaka Tatano; Chiaki Sano; Toshiaki Shimizu
Development of new antituberculous drugs based on bacterial virulence factors interfering with host cytokine networks.
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 2011;17(3):302-17.
2011: Chiaki Sano; Yutaka Tatano; Toshiaki Shimizu; Seiko Yamabe; Katsumasa Sato; Haruaki Tomioka
Comparative in vitro and in vivo antimicrobial activities of sitafloxacin, gatifloxacin and moxifloxacin against Mycobacterium avium.
International journal of antimicrobial agents 2011;37(4):296-301.
2010: Yutaka Tatano; K Yasumoto; Toshiaki Shimizu; Chiaki Sano; Katsumasa Sato; S Yano; H Takeyama; Haruaki Tomioka
Comparative study for the virulence of Mycobacterium avium isolates from patients with nodular-bronchiectasis- and cavitary-type diseases.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2010;29(7):801-6.
2010: Toshiaki Shimizu; Ko Yasumoto; Yutaka Tatano; Haruaki Tomioka; Katsumasa Sato; Chiaki Sano; Hiromi Kumon; Koichi Monden
In vitro drug susceptibility of Mycobacterium bovis BCG Connaught and Tokyo strains.
The Journal of infection 2010;60(3):248-51.
2009: Mitsuhiro Kimura; Ryouji Hamamura; Tsuyoshi Umehara; Noriaki Aoi; Chiaki Sano; Shingo Kataoka; Hideyuki Kawauchi
[Caloric test in low-tone sensorineural hearing loss].
Nihon Jibiinkoka Gakkai kaiho 2009;112(8):615-22.
2007: Chiaki Sano; Toshiaki Shimizu; Yutaka Tatano; Ko Yasumoto; Haruaki Tomioka
[Profiles of intracellular expression, distribution, and activation of phospholipase A2 in host macrophages infected with Mycobacterium avium complex].
Kansenshōgaku zasshi. The Journal of the Japanese Association for Infectious Diseases 2007;81(6):695-9.
2006: Shanshan Cai; Katsumasa Sato; Toshiaki Shimizu; Seiko Yamabe; Miho Hiraki; Chiaki Sano; Haruaki Tomioka
Antimicrobial activity of picolinic acid against extracellular and intracellular Mycobacterium avium complex and its combined activity with clarithromycin, rifampicin and fluoroquinolones.
The Journal of antimicrobial chemotherapy 2006;57(1):85-93.
2005: Haruaki Tomioka; Chiaki Sano; Katsumasa Sato; Keiko Ogasawara; Tatsuya Akaki; Keisuke Sano; Shan Shan Cai; Toshiaki Shimizu
Combined effects of ATP on the therapeutic efficacy of antimicrobial drug regimens against Mycobacterium avium complex infection in mice and roles of cytosolic phospholipase A2-dependent mechanisms in the ATP-mediated potentiation of antimycobacterial host resistance.
Journal of immunology (Baltimore, Md. : 1950) 2005;175(10):6741-9.
2005: Haruaki Tomioka; Katsumasa Sato; Toshiaki Shimizu; Chiaki Sano
[Adjunctive immunotherapy of mycobacterial infections].
Nihon saikingaku zasshi. Japanese journal of bacteriology 2005;60(3):445-52.
2005: Katsumasa Sato; Toshiaki Shimizu; Chiaki Sano; Haruaki Tomioka
Effects of type II alveolar epithelial cells on T cell mitogenic responses to concanavalin A and purified protein derivatives.
Microbiology and immunology 2005;49(10):885-90.
2004: Chiaki Sano; Toshiaki Shimizu; Katsumasa Sato; Haruaki Tomioka
[Profiles of the expression of phospholipase A2 family mRNAs by macrophages infected with Mycobacterium tuberculosis].
Kansenshōgaku zasshi. The Journal of the Japanese Association for Infectious Diseases 2004;78(6):503-7.
2004: Keisuke Sano; Haruaki Tomioka; Katsumasa Sato; Chiaki Sano; Hideyuki Kawauchi; Shanshan Cai; Toshiaki Shimizu
Interaction of antimycobacterial drugs with the anti-Mycobacterium avium complex effects of antimicrobial effectors, reactive oxygen intermediates, reactive nitrogen intermediates, and free fatty acids produced by macrophages.
Antimicrobial agents and chemotherapy 2004;48(6):2132-9.
2004: Toshiaki Shimizu; Chiaki Sano; Haruaki Tomioka
The role of B7 molecules in the cell contact-mediated suppression of T cell mitogenesis by immunosuppressive macrophages induced with mycobacterial infection.
Clinical and experimental immunology 2004;135(3):373-9.
2004: H Tomioka; T Shimizu; K Sato; Chiaki Sano; T Kamei; M Emori; H Saito
Comparative roles of macrophages and NK cells in the host innate resistance of mice to Mycobacterium fortuitum infection.
The Journal of infection 2004;48(1):74-80.
2003: Chiaki Sano; Toshiaki Shimizu; Haruaki Tomioka
Effects of secretory leukocyte protease inhibitor on the tumor necrosis factor-alpha production and NF-kappaB activation of lipopolysaccharide-stimulated macrophages.
Cytokine 2003;21(1):38-42.
2003: Toshiaki Shimizu; Katsumasa Sato; Chiaki Sano; Keisuke Sano; Haruaki Tomioka
[Effects of antisense oligo DNA on the antimicrobial activity of reactive oxygen intermediates and antimycobacterial agents against Mycobacterium avium complex].
Kekkaku : [Tuberculosis] 2003;78(1):33-5.
2002: Toshiaki Shimizu; Haruaki Tomioka; Masanori Matsuoka; Chiaki Sano
Profiles of the mRNA expression by macrophages infected with Mycobacterium leprae and Mycobacterium avium complex.
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association 2002;70(4):250-9.
2002: Keiko Ogasawara; Haruaki Tomioka; Toshiaki Shimizu; Chiaki Sano; Hideyuki Kawauchi; Katsumasa Sato
Profiles of cell-to-cell interaction of Mycobacterium intracellulare-induced immunosuppressive macrophages with target T cells in terms of suppressor signal transmission.
Clinical and experimental immunology 2002;129(2):272-80.
2002: Katsumasa Sato; Haruaki Tomioka; Toshiaki Shimizu; Tatsuo Gonda; Fusao Ota; Chiaki Sano
Type II alveolar cells play roles in macrophage-mediated host innate resistance to pulmonary mycobacterial infections by producing proinflammatory cytokines.
The Journal of infectious diseases 2002;185(8):1139-47.
2002: H Tomioka; K Sato; T Shimizu; Chiaki Sano
Anti-Mycobacterium tuberculosis activities of new fluoroquinolones in combination with other antituberculous drugs.
The Journal of infection 2002;44(3):160-5.
2002: Haruaki Tomioka; Chiaki Sano; Katsumasa Sato; Toshiaki Shimizu
Antimicrobial activities of clarithromycin, gatifloxacin and sitafloxacin, in combination with various antimycobacterial drugs against extracellular and intramacrophage Mycobacterium avium complex.
International journal of antimicrobial agents 2002;19(2):139-45.
2002: Haruaki Tomioka; Katsumasa Sato; Chiaki Sano; Keisuke Sano; Toshiaki Shimizu
Intramacrophage passage of Mycobacterium tuberculosis and M. avium complex alters the drug susceptibilities of the organisms as determined by intracellular susceptibility testing using macrophages and type II alveolar epithelial cells.
Antimicrobial agents and chemotherapy 2002;46(2):519-21.
2002: Keisuke Sano; Katsumasa Sato; Chiaki Sano; Toshiaki Shimizu; Haruaki Tomioka
Comparative profiles of intramacrophage behavior of Mycobacterium tuberculosis and Mycobacterium avium complex with different levels of virulence.
Microbiology and immunology 2002;46(7):483-6.
2001: Haruaki Tomioka; Toshiaki Shimizu; H Kajitani; Katsumasa Sato; Chiaki Sano
Expression profiles of low molecular mass heat shock proteins by Mycobacterium avium and Mycobacterium intracellulare.
FEMS microbiology letters 2001;200(2):131-6.
2001: Toshiaki Shimizu; Keiko Ogasawara; Katsumasa Sato; Chiaki Sano; Haruaki Tomioka
[Profiles of expression of the therapeutic efficacy of KRM-1648 in mice infected with Mycobacterium avium complex at different challenge doses].
Kekkaku : [Tuberculosis] 2001;76(5):413-8.
2001: Katsumasa Sato; Tatsuya Akaki; Toshiaki Shimizu; Chiaki Sano; Keiko Ogasawara; Haruaki Tomioka
[Invasion and intracellular growth of Mycobacterium tuberculosis and Mycobacterium avium complex adapted to intramacrophagic environment within macrophages and type II alveolar epithelial cells].
Kekkaku : [Tuberculosis] 2001;76(2):53-7.
1999: Toshiaki Shimizu; Chiaki Sano; Tatsuya Akaki; Keiko Ogasawara; Katsumasa Sato; Haruaki Tomioka
[Effects of the Chinese traditional medicines "mao-bushi-saishin-to" and "yokuinin" on the antimycobacterial activity of murine macrophages against Mycobacterium avium complex infection].
Kekkaku : [Tuberculosis] 1999;74(9):661-6.
1999: Chiaki Sano; Toshiaki Shimizu; Katsumasa Sato; Keiko Ogasawara; Haruaki Tomioka
[Effects of secretory leukocyte protease inhibitor on the production of some cytokines and nitric oxide by murine peritoneal macrophages in response to lipopolysaccharide stimulation and M. avium complex infection].
Kekkaku : [Tuberculosis] 1999;74(7):563-70.
1999: Chiaki Sano; Katsumasa Sato; Toshiaki Shimizu; H Kajitani; Hideyuki Kawauchi; Haruaki Tomioka
The modulating effects of proinflammatory cytokines interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha), and immunoregulating cytokines IL-10 and transforming growth factor-beta (TGF-beta), on anti-microbial activity of murine peritoneal macrophages against Mycobacterium avium-intracellulare complex.
Clinical and experimental immunology 1999;115(3):435-42.
1999: Toshiaki Shimizu; Haruaki Tomioka; Katsumasa Sato; Chiaki Sano; Tatsuya Akaki; Satoshi Dekio; Y Yamada; T Kamei; H Shibata; N Higashi
Effects of the Chinese traditional medicine mao-bushi-saishin-to on therapeutic efficacy of a new benzoxazinorifamycin, KRM-1648, against Mycobacterium avium infection in mice.
Antimicrobial agents and chemotherapy 1999;43(3):514-9.
1999: Chiaki Sano; Toshiaki Shimizu; Katsumasa Sato; Hideyuki Kawauchi; S Kawahara; Haruaki Tomioka
Therapeutic effects of benzoxazinorifamycin KRM-1648 administered alone or in combination with a half-sized secretory leukocyte protease inhibitor or the nonsteroidal anti-inflammatory drug diclofenac sodium against Mycobacterium avium complex infection in mice.
Antimicrobial agents and chemotherapy 1999;43(2):360-4.
1999: Toshiaki Shimizu; Haruaki Tomioka; Katsumasa Sato; Chiaki Sano; Y Yamada; H Shibata; N Higashi
Effects of Yokuinin on the therapeutic efficacy of a new benzoxazinorifamycin KRM-1648 against Mycobacterium avium infection.
International journal of antimicrobial agents 1999;11(1):69-74.
1997: Tatsuya Akaki; Katsumasa Sato; Toshiaki Shimizu; Chiaki Sano; H Kajitani; Satoshi Dekio; Haruaki Tomioka
Effector molecules in expression of the antimicrobial activity of macrophages against Mycobacterium avium complex: roles of reactive nitrogen intermediates, reactive oxygen intermediates, and free fatty acids.
Journal of leukocyte biology 1997;62(6):795-804.
1997: Toshiaki Shimizu; Chiaki Sano; Katsumasa Sato; Haruaki Tomioka
[Effects of various steroidal and non-steroidal anti-inflammatory drugs on in-vitro IL-10 production of murine peritoneal macrophages infected with Mycobacterium avium complex].
Kansenshōgaku zasshi. The Journal of the Japanese Association for Infectious Diseases 1997;71(9):910-7.
1997: Haruaki Tomioka; Katsumasa Sato; Chiaki Sano; Tatsuya Akaki; Toshiaki Shimizu; H Kajitani; H Saito
Effector molecules of the host defence mechanism against Mycobacterium avium complex: the evidence showing that reactive oxygen intermediates, reactive nitrogen intermediates, and free fatty acids each alone are not decisive in expression of macrophage antimicrobial activity against the parasites.
Clinical and experimental immunology 1997;109(2):248-54.
1997: Haruaki Tomioka; Katsumasa Sato; Toshiaki Shimizu; Chiaki Sano; Tatsuya Akaki; H Saito; K Fujii; T Hidaka
Effects of benzoxazinorifamycin KRM-1648 on cytokine production at sites of Mycobacterium avium complex infection induced in mice.
Antimicrobial agents and chemotherapy 1997;41(2):357-62.